SEER, INC. Debt Securities, Available-for-sale
SEER, INC. (SEER) had Debt Securities, Available-for-sale of $206.81 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-11
- 2026-06-30: Debt Securities, Available-for-sale $206.81M.
- 2026-03-31: Debt Securities, Available-for-sale $216.67M.
- 2025-12-31: Debt Securities, Available-for-sale $238.11M.
- 2025-09-30: Debt Securities, Available-for-sale $249.05M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-06-30 | $206.81M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $216.67M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $238.11M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $249.05M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $261.63M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $283.57M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $299.05M 10-K · filed 2026-03-02 |
| 2024-09-30 | $311.74M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $343.76M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $357.35M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $369.76M 10-K · filed 2025-03-03 |
| 2023-09-30 | $378.41M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $392.80M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $410.51M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $426.40M 10-K · filed 2024-03-04 |
| 2021-12-31 | $493.26M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |